Домашня сторінка
→
Хімічні та біологічні науки
→
Відділення біохімії, фізіології та молекулярної біології
→
Experimental Oncology
→
Experimental Oncology, 2013 (том 35)
→
Experimental Oncology, 2013, № 2
→
Перегляд Experimental Oncology, 2013, № 2 за датою випуску

Перегляд Experimental Oncology, 2013, № 2 за датою випуску

Результати 1-17 з 17

Recurrence of borderline ovarian tumors

Svintsitskiy, V.S.; Vorobyova, L.I.; Klymenko, E.S.; Dermenzhy, T.V.; Tkalya, J.G. (Experimental Oncology, 2013)

Aim - to increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 ...
Ukrain and its emerging role as an antineoplastic agent in systemic malignancies

Kapoor S. (Experimental Oncology, 2013)
The second Ukrainian-Swedish workshop "Translational oncology: old and new paradigms”

Автор відсутній (Experimental Oncology, 2013)
Tumor cell heterogeneity

Chekhun, V.F.; Sherban, S.D.; Savtsova, Z.D. (Experimental Oncology, 2013)

The paper deals with the analysis of literary data on the tumor cell heterogeneity. Phenotypic, genetic and epigenetic mechanisms of heterogeneity are considered. The heterogeneity or metastasis is considered too. The ...
Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells

Gerashchenko, O.L.; Zhuravel, E.V.; Skachkova, O.V.; Khranovska, N.N.; Filonenko, V.V.; Pogrebnoy, P.V.; Soldatkina, M.A. (Experimental Oncology, 2013)

Aim - the aim of the study was in vitro analysis of biological activity of recombinant human beta-defensin-4 (rec-hBD-4). Methods: hBD-4 cDNA was cloned into pGEX-2T vector, and recombinant plasmid was transformed into E. ...
Optimization of physico-chemical properties of carbon enterosorbents and evaluation of their sorption activity for use in the treatment of paraneoplastic syndrome and other endogenous intoxications in cancer patients

Sarnatskaya, V.V.; Sidorenko, A.S.; Klymchuk, D.A.; Khohulya, I.M.; Yushko, L.A.; Maslenniy, V.N.; Nikolaev, V.G. (Experimental Oncology, 2013)

Aim - development of carbon enterosorbents with optimal physical-chemical properties and high adsorptive capacity for their usage in the treatment of paraneoplastic syndrome and other endogenous intoxication in cancer ...
The level of anti-(GalNAc beta) and anti-para-Forssman disaccharide igg antibodies in patients with gastrointestinal cancer: relation to survival

Smorodin, E.P.; Kurtenkov, O.A.; Sergeyev, B.L. (Experimental Oncology, 2013)

Serum anti-(GalNAc beta) and anti-para-Forssman disaccharide (PFdi, GalNAc beta1 - 3GalNAc beta) IgG levels were earlier found to be related to histological grading and progression of gastrointestinal cancer. Aim - to study ...
Possible interference of human beta-herpesviruses-6 and -7 in gastrointestinal cancer development

Sultanova A.; Chistjakovs M.; Chapenko S.; Donina S.; Murovska M. (Experimental Oncology, 2013)

Aim: The high incidence of gastrointestinal cancer combined with high mortality from the disease if diagnosed at a late stage, signifies the need for better diagnostic, prognostic and predictive tools. Human beta-herpesviruses ...
Serum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment

Subramanyam D.; Subbaiah, K.C.V.; Rajendra W.; Lokanatha V. (Experimental Oncology, 2013)

Aim - in the present study, the effect of chemo and radio therapies on serum trace elements content and antioxidant activity in blood serum of cervical cancer patients was evaluated. Among 104 cervical cancer patients ...
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients

Fishchuk, L.E.; Gorovenko, N.G. (Experimental Oncology, 2013)

Background: breast cancer (BC) is one of the most common cancer pathologies in women. Genetic polymorphism of genes of reninangiotensin system (RAS) is considered to be associated with cancer development, in particular, ...
Treatment of large osteosarcoma in children: new approach

Kobys, V.L.; Konovalenko, V.F.; Repinа, N.V.; Golovko, T.S.; Gulak, L.O.; Tarasova, T.O.; Zaharycheva, E.V.; Matyushok, O.F. (Experimental Oncology, 2013)

Aim - to improve the treatment results of patients with locally advanced osteosarcoma with large volume using neoadjuvant chemotherapy (NACT) (ifosfamide at a dose of 18 g/ml) and planning of organ-conserving surgery by ...
Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer

Skachkova, O.V.; Khranovska, N.M.; Gorbach, O.I.; Svergun, N.M.; Sydor, R.I.; Nikulina, V.V. (Experimental Oncology, 2013)

Aim - to investigate the quantitative and functional status of peripheral blood lymphocytes in patients with non-small cell lung cancer during DC-vaccine therapy and identify the most informative immunological parameters ...
Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach

Vernygorodskyi S. (Experimental Oncology, 2013)

Aim - to assess the profile of mucins (MUC1, MUC2, MUC5AC) in gastric mucosa through immunohistochemical method. To identify metaplastic areas in gastric mucosa there was used chromoendoscopy with 0,5 % solution of methylene ...
Chronic periodontitis and the risk of head and neck squamous cell carcinoma: facts and figures

Gondivkar, S.M.; Gondivkar, R.S.; Gadbail, A.R.; Chole R.; Mankar M.; Yuwanati M. (Experimental Oncology, 2013)

Substantial evidence supports an association between periodontal disease and several systemic diseases including cardiovascular diseases, diabetes mellitus, respiratory diseases, adverse pregnancy outcomes, osteoporosis ...
Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial ¹⁷⁷Lu/⁹⁰Y-DOTATOC and ²¹³Bi-DOTATOC radiopeptide therapy

Giesel, F.L.; Flechsig P.; Kuder T.; Schwartz L.; Wulfert S.; Zechmann C.; Bruchertseifer F.; Haberkorn U.; Kratochwil C. (Experimental Oncology, 2013)

Aim - radiopeptide therapy with beta emitter labeled ¹⁷⁷Lu/⁹⁰Y- DOTA(0)-Phe(1)-Tyr(3)-octreotide (DOTATOC) and more recently also alpha emitting ²¹³Bi-DOTATOC are promising new treatments for neuroendocrine tumors. No early ...
TNFα receptor1 drives hypoxia-promoted invasiveness of human melanoma cells

Marconi C.; Peppicelli S.; Bianchini F.; Calorini L. (Experimental Oncology, 2013)

Aim: Oxygen deprivation leading to hypoxia represents a common feature of advanced solid tumors, able to control several aspects of tumor progression. Indeed, ability to respond to changes in oxygen partial pressure ...
Serum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment

Subramanyam D.; Subbaiah, K.C.V.; Rajendra W.; Lokanatha V. (Experimental Oncology, 2013)

Aim - in the present study, the effect of chemo and radio therapies on serum trace elements content and antioxidant activity in blood serum of cervical cancer patients was evaluated. Among 104 cervical cancer patients ...

Результати 1-17 з 17

Пошук

Розширений пошук

Перегляд

Вся бібліотека
Колекція

Перегляд Experimental Oncology, 2013, № 2 за датою випуску

Репозиторій DSpace/Manakin

Перегляд Experimental Oncology, 2013, № 2 за датою випуску

Пошук

Перегляд

Вся бібліотека

Колекція

Мій обліковий запис